An Estimation of the Economic and Environmental Impact of Inhaler Devices Switch for Non-Clinical Reasons in COPD and Asthma: The Case for Spain
Oriol Solà-Morales, Joan B Soriano, Míriam Solozabal-Coll, Jose Vicente Galindo

TL;DR
Switching inhalers for non-clinical reasons in Spain leads to significant economic and environmental costs for COPD and asthma patients.
Contribution
Quantifies the economic and environmental impact of non-clinical inhaler switching in Spain for COPD and asthma.
Findings
Uncontrolled switching in COPD costs EUR 923/patient annually, totaling EUR 216 million.
Asthma patients face EUR 263/patient annual costs, totaling EUR 118 million.
Environmental impact is nearly 45,000 tCO2eq, with training reducing emissions by 2,600 tCO2eq.
Abstract
In respiratory patients, limited adherence to and misuse of devices hinder the effectiveness of inhalation therapy. Switching inhalers for non-clinical reasons poses a risk of deterioration of respiratory disease and/or promotes poor adherence to therapy. The objective of this work was to explore the impact of device changes for non-clinical reasons on clinical outcomes (primary) and costs (secondary), including carbon emissions in Spain. After a comprehensive literature search, the increased use of resources following worsening outcomes was apportioned using Spanish cost data and following the recommended pathways for care. We calculated the cost of re-training these patients and attributed carbon emissions in metric tons of CO2 equivalent (tCO2eq) to the excess resource use. In Spain, the impact of uncontrolled switching for non-clinical reasons in COPD has an annual estimated cost of…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInhalation and Respiratory Drug Delivery · Air Quality and Health Impacts · Chronic Obstructive Pulmonary Disease (COPD) Research
